Skip to Content
You are currently on the new version of our website. Access the old version .

4,211 Results Found

  • Article
  • Open Access
30 Citations
9,223 Views
15 Pages

17 January 2024

This study aimed to elucidate the long-term progression of mild cognitive impairment (MCI) within a comprehensive longitudinal dataset, distinguish it from healthy aging, explore the influence of a dementia subtype on this progression, and identify p...

(This article belongs to the Section Clinical Neurology)
  • Article
  • Open Access
51 Citations
7,864 Views
16 Pages

Working Memory Decline in Alzheimer’s Disease Is Detected by Complexity Analysis of Multimodal EEG-fNIRS

  • David Perpetuini,
  • Antonio Maria Chiarelli,
  • Chiara Filippini,
  • Daniela Cardone and ,
  • Pierpaolo Croce,
  • Ludovica Rotunno,
  • Nelson Anzoletti,
  • Michele Zito,
  • Filippo Zappasodi and
  • Arcangelo Merla
  • + 5 authors+ 0 author

6 December 2020

Alzheimer’s disease (AD) is characterized by working memory (WM) failures that can be assessed at early stages through administering clinical tests. Ecological neuroimaging, such as Electroencephalography (EEG) and functional Near Infrared Spec...

(This article belongs to the Section Information Theory, Probability and Statistics)
  • Brief Report
  • Open Access
5 Citations
3,334 Views
8 Pages

18F–THK–5351, Fluorodeoxyglucose, and Florbetaben PET Images in Atypical Alzheimer’s Disease: A Pictorial Insight into Disease Pathophysiology

  • Sohee Park,
  • Minyoung Oh,
  • Jae Seung Kim,
  • Jae-Hong Lee and ,
  • Young Wook Yoon and
  • Jee-Hoon Roh
  • + 1 author+ 0 author

The recent advance of positron emission tomography (PET) tracers as biomarkers in Alzheimer’s disease (AD) provides more insight into pathophysiology, preclinical diagnosis, and further therapeutic strategies. However, synergistic processes or intera...

  • Article
  • Open Access
2 Citations
2,809 Views
25 Pages

This paper examines the regressive nature of the value-added tax and proposes an integrated framework combining a uniform value-added tax rate with progressive, digitally administered rebates. The model was performed using household- and firm-level m...

(This article belongs to the Section Business and Entrepreneurship)
  • Article
  • Open Access
10 Citations
3,695 Views
22 Pages

Employing Deep-Learning Approach for the Early Detection of Mild Cognitive Impairment Transitions through the Analysis of Digital Biomarkers

  • Rajaram Narasimhan,
  • Muthukumaran Gopalan,
  • Mohamed Yacin Sikkandar,
  • Ahmad Alassaf and ,
  • Ibrahim AlMohimeed,
  • Khalid Alhussaini,
  • Adham Aleid and
  • Sabarunisha Begum Sheik
  • + 3 authors+ 0 author

31 October 2023

Mild cognitive impairment (MCI) is the precursor to the advanced stage of Alzheimer’s disease (AD), and it is important to detect the transition to the MCI condition as early as possible. Trends in daily routines/activities provide a measuremen...

(This article belongs to the Section Wearables)
  • Article
  • Open Access
351 Views
23 Pages

The complexity involved in predicting the progression of Alzheimer’s Disease (AD) occurs because of differences in neuroimaging data and the many inconsistencies in biomarker data and cognitive data alike. The current research examined an AI mo...

  • Article
  • Open Access
2 Citations
715 Views
24 Pages

13 June 2026

Urban low-altitude unmanned aerial vehicle (UAV) logistics networks face critical operational bottlenecks due to complex three-dimensional spatial blockages, continuous communication diffraction, and severe vulnerability to information-layer threats...

(This article belongs to the Section Remote Sensors)
  • Article
  • Open Access
16 Citations
5,382 Views
26 Pages

Differences in Immune-Related Genes Underlie Temporal and Regional Pathological Progression in 3xTg-AD Mice

  • Adelaide Fernandes,
  • Cláudia Caldeira,
  • Carolina Cunha,
  • Elisabete Ferreiro and ,
  • Ana Rita Vaz and
  • Dora Brites
  • + 1 author+ 0 author

1 January 2022

The prevalence of Alzheimer’s disease (AD), the most common cause of age-associated dementia, is estimated to increase over the next decades. Evidence suggests neuro-immune signaling deregulation and risk genes beyond the amyloid-β (A&beta...

(This article belongs to the Special Issue The Contribution of Non-Neuronal Cells in Neurodegeneration: From Molecular Pathogenesis to Therapeutic Challenges)
  • Article
  • Open Access
21 Citations
4,831 Views
19 Pages

Progressive Vascular Abnormalities in the Aging 3xTg-AD Mouse Model of Alzheimer’s Disease

  • Amandine Jullienne,
  • Ryan Quan,
  • Jenny I. Szu,
  • Michelle V. Trinh and ,
  • Erik J. Behringer and
  • Andre Obenaus
  • + 1 author+ 0 author

Vascular dysfunction and structural abnormalities in Alzheimer’s disease (AD) are known to contribute to the progression of the pathology, and studies have tended to ignore the role of the vasculature in AD progression. We utilized the 3xTg-AD...

(This article belongs to the Special Issue Alzheimer's Disease—115 Years after Its Discovery)
  • Review
  • Open Access
11 Citations
6,413 Views
25 Pages

Recent Progress in the Conversion of Methylfuran into Value-Added Chemicals and Fuels

  • Wei Wang,
  • Jiamin Yan,
  • Mengze Sun,
  • Xiufeng Li and ,
  • Yanqing Li,
  • Ling An,
  • Chi Qian,
  • Xing Zhang,
  • Xianzhao Shao and
  • Guangyi Li
  • + 6 authors+ 1 author

22 June 2024

2-methylfuran is a significant organic chemical raw material which can be produced by hydrolysis, dehydration, and selective hydrogenation of biomass hemicellulose. 2-methylfuran can be converted into value-added chemicals and liquid fuels. This arti...

(This article belongs to the Special Issue Feature Papers in Applied Chemistry: 3rd Edition)
  • Article
  • Open Access
6 Citations
4,965 Views
17 Pages

10 October 2021

Value added tax (VAT) has proven to be the most stable and revenue productive of all components of the tax system. However, for such a tax system to be policy sustainable over time, taxpayers must consider it fair, and it must be viewed by the Nation...

(This article belongs to the Special Issue Fiscal Policy, the Theory and its Role in a Future Sustainable Economy Development)
  • Article
  • Open Access
33 Citations
9,300 Views
25 Pages

8 March 2020

The article proves that despite a significant growth in the service sector in recent years, industry remains the main engine of economic growth. Moreover, using the analysis of statistical data, it is shown that the development of industrial complexe...

(This article belongs to the Section Economic and Business Aspects of Sustainability)
  • Article
  • Open Access
2 Citations
1,685 Views
11 Pages

Background: This study aims to determine whether including genetics as a risk factor for progression will improve the accuracy of the models used in newly diagnosed exfoliation glaucoma patients. Methods: This was a prospective cohort study. This stu...

(This article belongs to the Special Issue Glaucoma: New Diagnostic and Therapeutic Approaches)
  • Review
  • Open Access
24 Citations
11,373 Views
18 Pages

26 February 2022

Alzheimer’s disease (AD) is an age-related, progressive neurodegenerative disorder characterized by impaired cognition, memory loss, and altered personality. Many of the available pharmaceutical treatments do not alter the onset of disease prog...

(This article belongs to the Section Geriatric Neurology)
  • Review
  • Open Access
50 Citations
7,361 Views
19 Pages

Electrocatalytic Reactions for Converting CO2 to Value-Added Products: Recent Progress and Emerging Trends

  • Zohreh Masoumi,
  • Meysam Tayebi,
  • Mahdi Tayebi,
  • S. Ahmad Masoumi Lari and ,
  • Nethmi Sewwandi,
  • Bongkuk Seo,
  • Choong-Sun Lim,
  • Hyeon-Gook Kim and
  • Daeseung Kyung
  • + 4 authors+ 0 author

Carbon dioxide (CO2) emissions are an important environmental issue that causes greenhouse and climate change effects on the earth. Nowadays, CO2 has various conversion methods to be a potential carbon resource, such as photocatalytic, electrocatalyt...

(This article belongs to the Section Physical Chemistry and Chemical Physics)
  • Feature Paper
  • Review
  • Open Access
1 Citations
3,373 Views
22 Pages

Recent Progress in Seawater Splitting Hydrogen Production Assisted by Value-Added Electrooxidation Reactions

  • Yuanping Guo,
  • Chenghao Yang,
  • Jianli Yang,
  • Xin Xiao and ,
  • Maofei Ran and
  • Jing Li
  • + 1 author+ 0 author

6 June 2025

Electrolysis of abundant seawater resources is a promising approach for hydrogen production. However, the high-concentration chloride ion in seawater readily induces the chlorine evolution reaction (CER), resulting in catalyst degradation and decreas...

(This article belongs to the Section D: Energy Storage and Application)
  • Feature Paper
  • Article
  • Open Access
7 Citations
4,688 Views
13 Pages

Predicting the Risk of Alzheimer’s Disease and Related Dementia in Patients with Mild Cognitive Impairment Using a Semi-Competing Risk Approach

  • Zhaoyi Chen,
  • Yuchen Yang,
  • Dazheng Zhang,
  • Jingchuan Guo and ,
  • Yi Guo,
  • Xia Hu,
  • Yong Chen and
  • Jiang Bian
  • + 3 authors+ 0 author

Alzheimer’s disease (AD) and AD-related dementias (AD/ADRD) are a group of progressive neurodegenerative diseases. The progression of AD can be conceptualized as a continuum in which patients progress from normal cognition to preclinical AD (i....

(This article belongs to the Special Issue Feature Papers in Medical and Clinical Informatics)
  • Review
  • Open Access
34 Citations
7,661 Views
34 Pages

16 December 2020

Alzheimer’s disease (AD) is the most common cause of dementia, typically showing progressive neurodegeneration in aging brains. The key signatures of the AD progression are the deposition of amyloid-beta (Aβ) peptides, the formation of tau...

(This article belongs to the Special Issue Alzheimer’s Disease and Other Dementias-Novel Therapeutic Approaches)
  • Review
  • Open Access
40 Citations
6,576 Views
21 Pages

16 August 2021

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that manifests as cognitive deficits and memory decline, especially in old age. Several biomarkers have been developed to monitor AD progression. Given that the retina and brain sha...

(This article belongs to the Special Issue Molecular Aspects of Cellular Dysfunction in Alzheimer's Disease)
  • Review
  • Open Access
35 Citations
7,045 Views
21 Pages

15 October 2021

Sporadic Alzheimer’s Disease (AD) is the most common form of dementia, and its severity is characterized by the progressive formation of tau neurofibrillary tangles along a well-described path through the brain. This spatial progression provides the...

(This article belongs to the Special Issue Selective Vulnerability in Neurodegenerative Diseases)
  • Article
  • Open Access
4 Citations
2,338 Views
19 Pages

Recent epidemiological studies have indicated that exposure to particulate matter with an aerodynamic diameter of 2.5 μm or less in the ambient air (PM2.5) is significantly associated with an elevated risk of developing Alzheimer’s disease (...

(This article belongs to the Section Molecular Neurobiology)
  • Communication
  • Open Access
3 Citations
3,479 Views
8 Pages

4 November 2024

Background: Among the cognitive markers, the deterioration of semantic and phonemic verbal fluency seems to be an early indicator of Alzheimer’s disease (AD). The aims of this study are (1) to evaluate both types of verbal fluency in the early...

  • Review
  • Open Access
4 Citations
16,538 Views
24 Pages

Molecular Mechanisms Underlying Alzheimer’s Disease Pathogenesis: Comprehensive Overview

  • Filomena Lo Vecchio,
  • Annamaria la Torre,
  • Carolina Gravina,
  • Grazia D’Onofrio and
  • Antonio Greco

Alzheimer’s disease (AD) is a progressive, multifactorial neurodegenerative disorder ranking first as cause of dementia in the elderly. It is characterized by the progressive deterioration of the central nervous system, leading to impaired cogn...

(This article belongs to the Special Issue Molecular Mechanisms of Alzheimer’s Disease)
  • Review
  • Open Access
35 Citations
6,560 Views
28 Pages

Recent Progress on Biological Activity of Amaryllidaceae and Further Isoquinoline Alkaloids in Connection with Alzheimer’s Disease

  • Lucie Cahlíková,
  • Rudolf Vrabec,
  • Filip Pidaný,
  • Rozálie Peřinová and ,
  • Negar Maafi,
  • Abdullah Al Mamun,
  • Aneta Ritomská,
  • Viriyanata Wijaya and
  • Gerald Blunden
  • + 4 authors+ 0 author

29 August 2021

Alzheimer’s disease (AD) is a progressive age-related neurodegenerative disease recognized as the most common form of dementia among elderly people. Due to the fact that the exact pathogenesis of AD still remains to be fully elucidated, the treatment...

(This article belongs to the Section Natural Products Chemistry)
  • Review
  • Open Access
28 Citations
5,829 Views
22 Pages

Phototherapy of Alzheimer’s Disease: Photostimulation of Brain Lymphatics during Sleep: A Systematic Review

  • Oxana Semyachkina-Glushkovskaya,
  • Thomas Penzel,
  • Mikhail Poluektov,
  • Ivan Fedosov and ,
  • Maria Tzoy,
  • Andrey Terskov,
  • Inna Blokhina,
  • Viktor Sidorov and
  • Jürgen Kurths
  • + 4 authors+ 0 author

The global number of people with Alzheimer’s disease (AD) doubles every 5 years. It has been established that unless an effective treatment for AD is found, the incidence of AD will triple by 2060. However, pharmacological therapies for AD have...

(This article belongs to the Special Issue Recent Advances in Alzheimer’s Disease)
  • Article
  • Open Access
38 Citations
7,107 Views
15 Pages

Diagnostic Blood Biomarkers in Alzheimer’s Disease

  • Jung Eun Park,
  • Tamil Iniyan Gunasekaran,
  • Yeong Hee Cho,
  • Seong-Min Choi and ,
  • Min-Kyung Song,
  • Soo Hyun Cho,
  • Jahae Kim,
  • Ho-Chun Song,
  • Kyu Yeong Choi and
  • Byeong C. Kim
  • + 11 authors+ 6 authors

Potential biomarkers for Alzheimer’s disease (AD) include amyloid β1–42 (Aβ1–42), t-Tau, p-Tau181, neurofilament light chain (NFL), and neuroimaging biomarkers. Their combined use is useful for diagnosing and monitoring th...

(This article belongs to the Special Issue Molecular Mechanisms and Treatments on Neurodegenerative Diseases)
  • Review
  • Open Access
2 Citations
2,538 Views
25 Pages

Mitochondrial Dysfunction in Alzheimer’s Disease and Mitochondria-Targeted Therapeutics

  • Jasbir Bisht,
  • Priyanka Rawat,
  • Andrew C. Shin and
  • Vijay Hegde

28 May 2026

Alzheimer’s disease (AD) is the most prevalent form of dementia and is characterized by progressive cognitive decline due to the loss of neurons. The accumulation of extracellular senile plaques (Aβ) and intracellular tau neurofibrillary t...

(This article belongs to the Special Issue Pathological Mechanisms and Therapeutic Strategies of Alzheimer’s Disease)
  • Article
  • Open Access
17 Citations
5,771 Views
17 Pages

Reduction of Amyloid Burden by Proliferated Homeostatic Microglia in Toxoplasma gondii-Infected Alzheimer’s Disease Model Mice

  • Ji-Hun Shin,
  • Young Sang Hwang,
  • Bong-Kwang Jung,
  • Seung-Hwan Seo and ,
  • Do-Won Ham and
  • Eun-Hee Shin
  • + 1 author+ 0 author

In this study, we confirmed that the number of resident homeostatic microglia increases during chronic Toxoplasma gondii infection. Given that the progression of Alzheimer’s disease (AD) worsens with the accumulation of amyloid β (Aβ) plaques, which...

(This article belongs to the Section Molecular Neurobiology)
  • Review
  • Open Access
14 Citations
8,417 Views
27 Pages

30 November 2023

Alzheimer’s disease (AD) is a progressive neurodegenerative disease and a major cause of age-related dementia, characterized by cognitive dysfunction and memory impairment. The underlying causes include the accumulation of beta-amyloid protein...

(This article belongs to the Section Physiology and Pathology)
  • Review
  • Open Access
17 Citations
8,546 Views
17 Pages

Genomics: New Light on Alzheimer’s Disease Research

  • Yeong Ju Jung,
  • Yoon Ha Kim,
  • Mridula Bhalla,
  • Sung Bae Lee and
  • Jinsoo Seo

27 November 2018

Alzheimer’s disease (AD) is a progressive neurodegenerative disease that represents a major cause of death in many countries. AD is characterized by profound memory loss, disruptions in thinking and reasoning, and changes in personality and beh...

(This article belongs to the Special Issue Genomics of Brain Disorders)
  • Review
  • Open Access
59 Citations
9,650 Views
28 Pages

Molecular Dysfunctions of Mitochondria-Associated Membranes (MAMs) in Alzheimer’s Disease

  • Fanny Eysert,
  • Paula Fernanda Kinoshita,
  • Arnaud Mary,
  • Loan Vaillant-Beuchot and ,
  • Frédéric Checler and
  • Mounia Chami
  • + 1 author+ 0 author

14 December 2020

Alzheimer’s disease (AD) is a multifactorial neurodegenerative pathology characterized by a progressive decline of cognitive functions. Alteration of various signaling cascades affecting distinct subcellular compartment functions and their comm...

(This article belongs to the Special Issue Mitochondrial Protein Network: From Biogenesis to Bioenergetics in Health and Disease)
  • Review
  • Open Access
2,786 Views
19 Pages

Could Blood Transfusion Increase the Risk of Alzheimer’s Disease? A Narrative Review

  • Xiaoyue Li,
  • Renjun Pei,
  • Zhangcheng Fei,
  • Zhongsheng Chen and ,
  • Fangzhao Lin,
  • Pan Sun and
  • Haijun Cao
  • + 2 authors+ 0 author

20 February 2025

Alzheimer’s disease (AD) is the most common progressive neurodegenerative disease, and its pathogenesis is complex. In addition to amyloid-β and phosphorylated tau, inflammation and microbial infections also play a role in the development...

  • Review
  • Open Access
44 Citations
6,246 Views
13 Pages

Alzheimer’s disease (AD) is the most common neurodegenerative disorder, and is associated with several pathophysiological features, including cellular dysfunction, failure of neurotransmission, cognitive impairment, cell death, and other clinic...

(This article belongs to the Special Issue Alzheimer's Disease—115 Years after Its Discovery)
  • Review
  • Open Access
10 Citations
5,883 Views
28 Pages

22 January 2021

Currently, there is no cure for Alzheimer’s disease (AD) in humans; treatment is symptomatic only. Aging of the population, together with an unhealthy diet and lifestyle, contribute to the steady, global increase of AD patients. This increase c...

(This article belongs to the Special Issue Biomaterials for the Treatment and Diagnosis of Neurodegenerative Diseases)
  • Review
  • Open Access
251 Citations
46,701 Views
34 Pages

20 February 2021

Background. Alzheimer’s disease (AD) is a progressive neurodegenerative disorder affecting many individuals worldwide with no effective treatment to date. AD is characterized by the formation of senile plaques and neurofibrillary tangles, followed by...

(This article belongs to the Special Issue Pathogenesis of Alzheimer's Disease)
  • Review
  • Open Access
45 Citations
5,902 Views
14 Pages

miRNAs as Therapeutic Tools in Alzheimer’s Disease

  • Chang Youn Lee,
  • In Soo Ryu,
  • Jin-Hyeob Ryu and
  • Hyun-Jeong Cho

1 December 2021

Alzheimer’s disease (AD), an age-dependent, progressive neurodegenerative disorder, is the most common type of dementia, accounting for 50–70% of all dementia cases. Due to the increasing incidence and corresponding socioeconomic burden o...

(This article belongs to the Special Issue Alzheimer's disease: From Molecular Basis to Therapy)
  • Article
  • Open Access
207 Citations
14,897 Views
15 Pages

Altered Gut Microbial Metabolites in Amnestic Mild Cognitive Impairment and Alzheimer’s Disease: Signals in Host–Microbe Interplay

  • Li Wu,
  • Yuqiu Han,
  • Zhipeng Zheng,
  • Guoping Peng and ,
  • Ping Liu,
  • Siqing Yue,
  • Shuai Zhu,
  • Jun Chen,
  • Hanying Lv and
  • Baohong Wang
  • + 10 authors+ 5 authors

14 January 2021

Intimate metabolic host–microbiome crosstalk regulates immune, metabolic, and neuronal response in health and disease, yet remains untapped for biomarkers or intervention for disease. Our recent study identified an altered microbiome in patient...

(This article belongs to the Special Issue Gut Microbiota in Cognition, Behaviour and Alzheimer's Disease)
  • Review
  • Open Access
18 Citations
5,985 Views
16 Pages

The Systemic Effects of Exercise on the Systemic Effects of Alzheimer’s Disease

  • Dora Aczel,
  • Bernadett Gyorgy,
  • Peter Bakonyi,
  • RehAn BukhAri and ,
  • Ricardo Pinho,
  • Istvan Boldogh,
  • Gu Yaodong and
  • Zsolt Radak
  • + 3 authors+ 0 author

Alzheimer’s disease (AD) is a progressive degenerative disorder and a leading cause of dementia in the elderly. The etiology of AD is multifactorial, including an increased oxidative state, deposition of amyloid plaques, and neurofibrillary tan...

(This article belongs to the Section Health Outcomes of Antioxidants and Oxidative Stress)
  • Article
  • Open Access
9 Citations
3,762 Views
19 Pages

Early Changes in Transcriptomic Profiles in Synaptodendrosomes Reveal Aberrant Synaptic Functions in Alzheimer’s Disease

  • Xueqi Qu,
  • Li Lin,
  • Wanying Yi,
  • Changyu Sun and ,
  • Yuewen Chen and
  • Yu Chen
  • + 1 author+ 0 author

10 August 2022

Alzheimer’s disease (AD) is one of the most prevalent neurodegenerative disorders characterized by the progressive decline of cognitive functions, and is closely associated with the dysfunction of synapses, which comprise the basic structure th...

(This article belongs to the Special Issue The Pharmacology of Neurotransmission: Focus on Synaptic Alterations during Neurodegeneration and Treatments 2.0)
  • Review
  • Open Access
17 Citations
8,501 Views
32 Pages

Alzheimer’s disease (AD) is an irreversible neurodegenerative disease characterized by progressive cognitive decline. The two cardinal neuropathological hallmarks of AD include the buildup of cerebral β amyloid (Aβ) plaques and neurof...

(This article belongs to the Section Identification of Potential Biomarkers and Potential Therapeutic Targets)
  • Article
  • Open Access
13 Citations
3,367 Views
16 Pages

Alteration of Metabolic Profiles during the Progression of Alzheimer’s Disease

  • Wuhan Yu,
  • Lihua Chen,
  • Xuebing Li,
  • Tingli Han and ,
  • Yang Yang,
  • Cheng Hu,
  • Weihua Yu and
  • Yang Lü
  • + 3 authors+ 0 author

13 October 2023

(1) Background: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that threatens the population health of older adults. However, the mechanisms of the altered metabolism involved in AD pathology are poorly understood. The aim...

(This article belongs to the Section Molecular and Cellular Neuroscience)
  • Review
  • Open Access
7 Citations
3,316 Views
25 Pages

The Impact of the Exposome on Alzheimer’s Disease: The Influence of Nutrition

  • Martina Monaco,
  • Carola Torazza,
  • Ernesto Fedele and
  • Massimo Grilli

Alzheimer’s disease (AD) is a progressive neurodegenerative disease characterized by cognitive decline, memory loss, and behavioural changes. While genetic predispositions and pathological processes have been the traditional focus, this review...

(This article belongs to the Section Molecular Neurobiology)
  • Review
  • Open Access
79 Citations
10,272 Views
17 Pages

Epigenetic Changes in Alzheimer’s Disease: DNA Methylation and Histone Modification

  • Laura Maria De Plano,
  • Alessandra Saitta,
  • Salvatore Oddo and
  • Antonella Caccamo

21 April 2024

Alzheimer’s disease (AD) is a devastating neurodegenerative disorder characterized by progressive cognitive decline and memory loss, imposing a significant burden on affected individuals and their families. Despite the recent promising progress...

  • Review
  • Open Access
34 Citations
6,215 Views
36 Pages

The Interplay of Inflammation and Gut-Microbiota Dysbiosis in Alzheimer’s Disease: Mechanisms and Therapeutic Potential

  • Hanis Nabilah Abdol Samat,
  • Nurul Nadirah Razali,
  • Hazlina Mahadzir,
  • Tengku Sifzizul Tengku Muhammad and ,
  • King-Hwa Ling,
  • Nur Izzati Mansor and
  • Shahidee Zainal Abidin
  • + 2 authors+ 0 author

12 September 2025

Alzheimer’s disease (AD) represents a major global health challenge, characterised by progressive neurodegeneration that leads to cognitive decline. Inflammation is a key factor in the pathogenesis of AD, affecting both neuroinflammation and sy...

(This article belongs to the Section Molecular Genetics and Genomics)
  • Article
  • Open Access
13 Citations
3,126 Views
13 Pages

Background: Alzheimer’s disease (AD) is a neurodegenerative condition that has no definitive treatment, and its early diagnosis can help to prevent or slow down its progress. Structural magnetic resonance imaging (sMRI) and the progress of arti...

(This article belongs to the Section Machine Learning and Artificial Intelligence in Diagnostics)
  • Article
  • Open Access
15 Citations
3,682 Views
25 Pages

A Transcriptomics-Based Machine Learning Model Discriminating Mild Cognitive Impairment and the Prediction of Conversion to Alzheimer’s Disease

  • Min-Koo Park,
  • Jinhyun Ahn,
  • Jin-Muk Lim,
  • Minsoo Han and ,
  • Ji-Won Lee,
  • Jeong-Chan Lee,
  • Sung-Joo Hwang and
  • Keun-Cheol Kim
  • + 3 authors+ 0 author

19 November 2024

The clinical spectrum of Alzheimer’s disease (AD) ranges dynamically from asymptomatic and mild cognitive impairment (MCI) to mild, moderate, or severe AD. Although a few disease-modifying treatments, such as lecanemab and donanemab, have been...

(This article belongs to the Section Cellular Aging)
  • Article
  • Open Access
7 Citations
4,229 Views
14 Pages

Blood Analytes as Biomarkers of Mechanisms Involved in Alzheimer’s Disease Progression

  • Andrea Baldini,
  • Alberto Greco,
  • Mirko Lomi,
  • Roberta Giannelli and ,
  • Paola Canale,
  • Andrea Diana,
  • Cristina Dolciotti,
  • Renata Del Carratore and
  • Paolo Bongioanni
  • + 4 authors+ 0 author

31 October 2022

Alzheimer’s disease (AD) is the leading cause of dementia, but the pathogenetic factors are not yet well known, and the relationships between brain and systemic biochemical derangements and disease onset and progression are unclear. We aim to f...

(This article belongs to the Special Issue Quality of HDL and LDL: Metabolism, Nutrition, Exercise and Health Impact)
  • Review
  • Open Access
5 Citations
4,236 Views
19 Pages

WWOX Controls Cell Survival, Immune Response and Disease Progression by pY33 to pS14 Transition to Alternate Signaling Partners

  • Tsung-Yun Liu,
  • Ganesan Nagarajan,
  • Ming-Fu Chiang,
  • Shenq-Shyang Huang and ,
  • Tzu-Chia Lin,
  • Yu-An Chen,
  • Chun-I Sze and
  • Nan-Shan Chang
  • + 3 authors+ 0 author

7 July 2022

Tumor suppressor WWOX inhibits cancer growth and retards Alzheimer’s disease (AD) progression. Supporting evidence shows that the more strongly WWOX binds intracellular protein partners, the weaker is cancer cell growth in vivo. Whether this co...

(This article belongs to the Special Issue WWOX: A Fragile Tumor Suppressor with Pleotropic Functions)
  • Review
  • Open Access
986 Views
35 Pages

The pathological progression of Alzheimer’s disease (AD) involves not only intrinsic neuronal lesions but is also closely associated with dysregulation of intercellular communication within the neuroimmune microenvironment. Glycolysis, as a cen...

(This article belongs to the Section Bioinformatics and Systems Biology)
  • Review
  • Open Access
23 Citations
6,901 Views
45 Pages

28 October 2020

Alzheimer’s Disease (AD) is a progressive multifactorial age-related neurodegenerative disorder that causes the majority of deaths due to dementia in the elderly. Although various risk factors have been found to be associated with AD progressio...

(This article belongs to the Special Issue Molecular Mechanism of Alzheimer's Disease II)

of 85